These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 19722166)

  • 21. Dose-dependent pharmacokinetics of telithromycin after intravenous and oral administration to rats: contribution of intestinal first-pass effect to low bioavailability.
    Lee JH; Lee MG
    J Pharm Pharm Sci; 2007; 10(1):37-50. PubMed ID: 17498392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Etoposide bioavailability after oral administration of the prodrug etoposide phosphate in cancer patients during a phase I study.
    Chabot GG; Armand JP; Terret C; de Forni M; Abigerges D; Winograd B; Igwemezie L; Schacter L; Kaul S; Ropers J; Bonnay M
    J Clin Oncol; 1996 Jul; 14(7):2020-30. PubMed ID: 8683232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phytic acid enhances the oral absorption of isorhamnetin, quercetin, and kaempferol in total flavones of Hippophae rhamnoides L.
    Xie Y; Luo H; Duan J; Hong C; Ma P; Li G; Zhang T; Wu T; Ji G
    Fitoterapia; 2014 Mar; 93():216-25. PubMed ID: 24462958
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs.
    Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH
    Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Production, Characterization and Evaluation of Kaempferol Nanosuspension for Improving Oral Bioavailability.
    Qian YS; Ramamurthy S; Candasamy M; Shadab M; Kumar RH; Meka VS
    Curr Pharm Biotechnol; 2016; 17(6):549-55. PubMed ID: 26813303
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Gender on the Pharmacokinetics of ON 123300, A Dual Inhibitor of ARK5 and CDK4/6 for the Treatment of Cancer, in Rats.
    Mudunuru J; Ren C; Taft DR; Maniar M
    Eur J Drug Metab Pharmacokinet; 2019 Aug; 44(4):531-538. PubMed ID: 30701428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of a chemoprotective agent, 2-(allylthio)pyrazine, after intravenous and oral administration to rats: hepatic and gastric first-pass effects.
    Han KS; Lee MG
    Drug Metab Dispos; 1999 Feb; 27(2):221-6. PubMed ID: 9929506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatic and intestinal first-pass effects of oltipraz in rats.
    Bae SK; Kim JW; Kim YH; Kim YG; Kim SG; Lee MG
    Biopharm Drug Dispos; 2005 May; 26(4):129-34. PubMed ID: 15744718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma pharmacokinetics and bioavailability of 1-(2-chloroethyl)-3-sarcosinamide-1-nitrosourea after intravenous and oral administration to mice and dogs.
    Supko JG; Garcia-Carbonero R; Puchalski TA; Malspeis L
    Cancer Chemother Pharmacol; 2001 Sep; 48(3):202-8. PubMed ID: 11592341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of atorvastatin and its hydroxy metabolites in rats and the effects of concomitant rifampicin single doses: relevance of first-pass effect from hepatic uptake transporters, and intestinal and hepatic metabolism.
    Lau YY; Okochi H; Huang Y; Benet LZ
    Drug Metab Dispos; 2006 Jul; 34(7):1175-81. PubMed ID: 16624870
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics and bioavailability of the flavonoid 7,8-benzoflavone in rats.
    Wang X; Morris ME
    J Pharm Sci; 2008 Oct; 97(10):4546-56. PubMed ID: 18257033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improved oral bioavailability in rats of SR13668, a novel anti-cancer agent.
    Green CE; Swezey R; Bakke J; Shinn W; Furimsky A; Bejugam N; Shankar GN; Jong L; Kapetanovic IM
    Cancer Chemother Pharmacol; 2011 May; 67(5):995-1006. PubMed ID: 20623225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics and first-pass elimination of metoprolol in rats: contribution of intestinal first-pass extraction to low bioavailability of metoprolol.
    Yoon IS; Choi MK; Kim JS; Shim CK; Chung SJ; Kim DD
    Xenobiotica; 2011 Mar; 41(3):243-51. PubMed ID: 21128757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of the antimalarial drug, AQ-13, in rats and cynomolgus macaques.
    Ramanathan-Girish S; Catz P; Creek MR; Wu B; Thomas D; Krogstad DJ; De D; Mirsalis JC; Green CE
    Int J Toxicol; 2004; 23(3):179-89. PubMed ID: 15204721
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of quercetin on the bioavailability of doxorubicin in rats: role of CYP3A4 and P-gp inhibition by quercetin.
    Choi JS; Piao YJ; Kang KW
    Arch Pharm Res; 2011 Apr; 34(4):607-13. PubMed ID: 21544726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo efficacy studies of layer-by-layer nano-matrix bearing kaempferol for the conditions of osteoporosis: a study in ovariectomized rat model.
    Kumar A; Gupta GK; Khedgikar V; Gautam J; Kushwaha P; Changkija B; Nagar GK; Gupta V; Verma A; Dwivedi AK; Chattopadhyay N; Mishra PR; Trivedi R
    Eur J Pharm Biopharm; 2012 Nov; 82(3):508-17. PubMed ID: 22926146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Absorption, first-pass metabolism, and disposition of itraconazole in rats.
    Yoo SD; Kang E; Jun H; Shin BS; Lee KC; Lee KH
    Chem Pharm Bull (Tokyo); 2000 Jun; 48(6):798-801. PubMed ID: 10866139
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of intestinal availability of various drugs in the oral absorption process using portal vein-cannulated rats.
    Matsuda Y; Konno Y; Satsukawa M; Kobayashi T; Takimoto Y; Morisaki K; Yamashita S
    Drug Metab Dispos; 2012 Dec; 40(12):2231-8. PubMed ID: 22930277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preclinical pharmacokinetics of a novel HIV-1 attachment inhibitor BMS-378806 and prediction of its human pharmacokinetics.
    Yang Z; Zadjura L; D'Arienzo C; Marino A; Santone K; Klunk L; Greene D; Lin PF; Colonno R; Wang T; Meanwell N; Hansel S
    Biopharm Drug Dispos; 2005 Dec; 26(9):387-402. PubMed ID: 16142720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics and tissue distribution of halofuginone (NSC 713205) in CD2F1 mice and Fischer 344 rats.
    Stecklair KP; Hamburger DR; Egorin MJ; Parise RA; Covey JM; Eiseman JL
    Cancer Chemother Pharmacol; 2001 Nov; 48(5):375-82. PubMed ID: 11761455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.